2m 2m 2m 2m 2m 2m 2m
BOLT BIOTHERAP (BOLT)
NASDAQ
$3.95-$0.05 (-1.13%)
Price as of Aug 03, 2026 11:30 AM EDT- $7.7MMarket Cap
- -27.85%1-Year Change
- BiotechnologyIndustry
BOLT BIOTHERAP (BOLT)
$3.95-$0.05 (-1.13%)
BOLT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.99 | ||
Change | +$0.10 (+2.57%) | ||
Open | $3.97 | ||
High | $4.14 | ||
Low | $3.94 | ||
Previous Close | $3.89 | ||
Volume | 19,999 | ||
30-Day Average Volume | 14,842 | ||
1-Week Change | 4.18% | ||
1-Month Change | 3.64% | ||
1-Year Change | -27.85% | ||
3-Year Change | -85.22% | ||
5-Year Change | -98.21% | ||
Fundamentals | |||
Shares Outstanding | 1.9M | ||
Total Assets | $48.0M | ||
Market Cap | $7.7M | ||
Enterprise Value | -$3.9M | ||
Period: QTR TTM FY | |||
Revenue | $26,000.00 | ||
Net Income | -$7.2M | ||
Free Cash Flow | -$8.0M | ||
EBIT | -$7.2M | ||
EBITDA | -$7.0M | ||
Net Working Capital | $18.4M | ||
EPS | -$4.31 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | -152 | ||
P/B | 0 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 06/09/2025 | ||
Earnings & Revenue